Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
A study showed that the pandemic crunched the distance between our remembered events.
New research showed that 4,000 steps a day is associated with a lower risk of death.
Cheddar News checks in with a coast-to-coast forecast of the weather for Wednesday, Aug. 9, 2023.
COVID-19 hospital admissions have inched upward in the United States since early July in a small-scale echo of the three previous summers.
New data showed that the benefits of WeGovy go beyond weight loss.
Now that last month's sizzling numbers are all in, the European climate monitoring organization made it official: July 2023 was Earth's hottest month on record by a wide margin.
A new study found that a large number of women aged 70-85 are being overdiagnosed and overtreated for breast cancer.
Be Well: Why Black Maternal Death Rates Remain High
Covid cases are on the rise again and getting free tests is even more difficult.
A study shows air pollution is a factor in antibiotic resistance.
